Tg Therapeutics (TGTX) Operating Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly Operating Margin of 16.98% for Q1 2026, up 985.0% year-over-year from 1.56% in Q1 2025, and down 35.24% quarter-over-quarter from 26.22% in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Operating Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' Operating Margin history runs 10 years deep, the most recent figure standing at 16.98% for Q1 2026.
- In Q1 2026, Operating Margin rose 985.0% year-over-year to 16.98%; the TTM figure through Mar 2026 stood at 21.35% (up 586.0% YoY), while the FY2025 annual figure was 20.01%, up 727.0% from the prior year.
- Operating Margin for Q1 2026 stood at 16.98%, down from 26.22% in the prior quarter.
- The five-year high for Operating Margin was 69.22% in Q3 2023, with the low at 96923.75% in Q4 2022.
- The 5-year median for Operating Margin is 7.13% (2025), against an average of 8504.08%.
- The sharpest annual moves came in 2022 and 2023: Operating Margin sank 9291914 bps in 2022, then surged 9689536 bps in 2023.
- Tg Therapeutics' Operating Margin stood at 96923.75% in 2022, then soared by 100 bps to 28.39% in 2023, then jumped by 197 bps to 27.68% in 2024, then declined by 5 bps to 26.22% in 2025, then tumbled by 35 bps to 16.98% in 2026.
- Business Quant data shows TGTX's Operating Margin at 16.98% in Q1 2026, 26.22% in Q4 2025, and 18.16% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 19.75% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 9.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.02% |
| Mar 31, 2026 | 16.98% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 18.16% |
| Jun 30, 2025 | 24.69% |
| Mar 31, 2025 | 7.13% |
| Dec 31, 2024 | 27.68% |
| Sep 30, 2024 | 14.82% |
| Jun 30, 2024 | 12.00% |
| Mar 31, 2024 | -14.60% |
| Dec 31, 2023 | -28.39% |
| Sep 30, 2023 | 69.22% |
| Jun 30, 2023 | -277.93% |
| Mar 31, 2023 | -474.07% |
| Dec 31, 2022 | -96,923.75% |
| Sep 30, 2022 | -37,194.68% |
| Jun 30, 2022 | -6,555.72% |
| Mar 31, 2022 | -3,317.06% |
| Dec 31, 2021 | -4,004.61% |
| Sep 30, 2021 | -4,193.50% |